Health IT, EHR systems, telehealth, and clinical technology
Teladoc acquired UpLift in April 2025, embedding covered behavioral health into enterprise platforms as the $8.52B telehealth market pivots from video visits to chronic care ecosystems.
Snowflake research shows healthcare leaders repositioning data exchange infrastructure as foundation for AI scaling, reshaping vendor selection criteria.
IBM's December 2025 Confluent buy pushes healthcare enterprises to redirect 13-30% of IT budgets toward streaming platforms, cutting integration risk 40% while Oracle and GE trail in real-time governance.
Health Sector Coordinating Council mandates retroactive vendor assessments for AI tools already in production, targeting data leakage and adversarial threats. Compliance budgets rise as only 4% of organizations trust their current vendor evaluations.
Remote patient monitoring specialists now outpace general telehealth platforms in growth, forcing enterprises to reassess vendor strategies as AI-RPM integration becomes table stakes.
New research shows 85% of healthcare leaders elevated interoperability investment over 2024 levels, with AI scaling identified as the primary driver. The shift forces budget reallocations from EHR integrations to cross-platform data infrastructure.
Novo Nordisk's full-stack OpenAI deployment across R&D, trials, and manufacturing forces health systems to match scale or cede competitive ground.
Nordic Capital acquired Arcadia for an estimated $200M+ in April 2026, injecting growth capital into a platform serving 100M+ lives. Enterprise buyers gain negotiating leverage as private equity consolidates analytics vendors.
Ardent Health's February 2026 partnership with hellocare.ai brings AI-assisted virtual physicians and patient monitoring to 2,000+ rooms, targeting 20-30% labor savings amid nurse shortages.
Cotiviti's February 2026 acquisition of Edifecs consolidates payer interoperability leadership, with Edifecs ranking #1 in FHIR/EDI among 99 payers as cloud platforms capture two-thirds of the market.
Lilly's March agreement with Insilico Medicine—$115M upfront for 28 AI-designed drug candidates—marks the first billion-dollar-plus validation of end-to-end generative AI in drug discovery.
Greenway Health's Novare platform integrates clinical and revenue cycle management into a single AI-native EHR, challenging Epic's modular approach and raising baseline feature expectations across ambulatory care.